| HOME | SITEMAP | REGISTRATION | FEEDBACK | ALL COURSES | MY CME |
| CME Activity Information | |
| Release Date: | April 7, 2008 |
| Most Recent Review: | April 7, 2008* |
| Most Recent Update: | April 7, 2008 |
| Date Credit Expires: | April 7, 2010 |
| Time to Complete: | 1 hour |
| Medium: | Internet Online |
| *Click here to learn more about our review process. | |
*The CME quiz and evaluation must be completed by April 7, 2010, in order to receive the credit or participation certificate.
Target Audience
All information is submitted and reviewed and found to be scientifically rigorous, based on the best available evidence, fair and balanced, and free of commercial bias. All the recommendations involving clinical medicine in this CME activity are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection and analysis.
Any potential conflicts of interests are resolved via The Oncologist's anonymous peer review process: http://cme.theoncologist.com/misc/edboard.shtml. All manuscripts are reviewed by the Editorial Board with ad hoc assistance from two or more external experts in the field. All activity planners, authors, and reviewers are required to submit conflict of interest forms. These forms accompany the activity through the peer review process. Any reviewers who have a conflict of interest are recused. When a reviewer is recused, other suitable reviewers with no self-reported conflicts of interests are selected to conduct the reviews. All final publication decisions are made by the Editorial Board. The acceptance of a manuscript is based on its originality and importance to the field as assessed by the Editors.
Author Disclosure(s)Credentials: Medical Oncologist, Department of Clinical Oncology (Medical Oncology and Radiotherapy), Leiden University Medical Center, Leiden, The Netherlands.
Disclosures: The author has indicated no relevant commercial relationships.
Pancras C. W. Hogendoorn, M.D., Ph.D.
Credentials: Professor and Pathologist, Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Disclosures: The author has indicated no relevant commercial relationships.
Sander D. Dijkstra, M.D., Ph.D.
Credentials: Orthopedic Surgeon, Department of Orthopedics, Leiden University Medical Center, Leiden, The Netherlands.
Disclosures: The author has indicated no relevant commercial relationships.
Carla S. van Rijswijk, M.D., Ph.D.
Credentials: Radiologist, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
Disclosures: The author has indicated no relevant commercial relationships.
Augustinus D. Krol, M.D., Ph.D.
Credentials: Radiotherapist, Department of Clinical Oncology (Medical Oncology and Radiotherapy), Leiden University Medical Center, Leiden, The Netherlands.
Disclosures: The author has indicated no relevant commercial relationships.
Antonie H. M. Taminiau, M.D., Ph.D.
Credentials: Professor and Orthopedic Surgeon, Department of Orthopedics, Leiden University Medical Center, Leiden, The Netherlands.
Disclosures: The author has indicated no relevant commercial relationships.
Judith V. M. G. Bovée, M.D., Ph.D.
Credentials: Pathologist, Department of Pathology, Leiden
University Medical Center, Leiden, The Netherlands.
Disclosures: The author has indicated no relevant commercial
relationships.
| HOME | SITEMAP | REGISTRATION | FEEDBACK | ALL COURSES | MY CME |